{"id":"https://openalex.org/W2107849028","doi":"https://doi.org/10.1017/s1461145709000169","title":"Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial","display_name":"Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial","alternate_titles":[],"publication_year":2009,"publication_date":"2009-03-17","ids":{"openalex":"https://openalex.org/W2107849028","doi":"https://doi.org/10.1017/s1461145709000169","mag":"2107849028","pmid":"https://pubmed.ncbi.nlm.nih.gov/19288975","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3883127"},"language":"en","primary_location":{"id":"doi:10.1017/s1461145709000169","doi":"https://doi.org/10.1017/s1461145709000169","is_oa":false,"landing_page_url":"https://doi.org/10.1017/s1461145709000169","pdf_url":null,"source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2107849028"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://research.rug.nl/en/publications/80e9d99c-2ca6-4847-b8a6-eeb0de1b32fb","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055497986","display_name":"Sanjay J. Mathew","orcid":"https://orcid.org/0000-0002-2715-6641","observed_orcids":["https://orcid.org/0000-0002-2715-6641"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sanjay J. Mathew","raw_affiliation_strings":["Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA. sanjay.mathew@mssm.edu","Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA. sanjay.mathew@mssm.edu","institution_ids":["https://openalex.org/I98704320"]},{"raw_affiliation_string":"Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015678331","display_name":"James W. Murrough","orcid":"https://orcid.org/0000-0001-6286-1242","observed_orcids":["https://orcid.org/0000-0001-6286-1242"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James W. Murrough","raw_affiliation_strings":["Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044810280","display_name":"Marije aan het Rot","orcid":"https://orcid.org/0000-0001-6761-7513","observed_orcids":["https://orcid.org/0000-0001-6761-7513"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marije aan het Rot","raw_affiliation_strings":["Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083192238","display_name":"Katherine Anne Collins","orcid":"https://orcid.org/0000-0002-6717-879X","observed_orcids":["https://orcid.org/0000-0002-6717-879X"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine A. Collins","raw_affiliation_strings":["Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072386957","display_name":"David L. Reich","orcid":"https://orcid.org/0000-0003-0095-515X","observed_orcids":["https://orcid.org/0000-0003-0095-515X"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David L. Reich","raw_affiliation_strings":["Department of Anesthesiology, Mount Sinai School of Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anesthesiology, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012699156","display_name":"Dennis S. Charney","orcid":"https://orcid.org/0000-0003-0610-3433","observed_orcids":["https://orcid.org/0000-0003-0610-3433"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis S. Charney","raw_affiliation_strings":["Department of Neuroscience, Mount Sinai School of Medicine, New York, NY, USA","Department of Pharmacology & Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA","Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA","Office of the Dean, Mount Sinai School of Medicine, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]},{"raw_affiliation_string":"Department of Pharmacology & Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]},{"raw_affiliation_string":"Mood & Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]},{"raw_affiliation_string":"Office of the Dean, Mount Sinai School of Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5055497986"],"corresponding_institution_ids":["https://openalex.org/I98704320"],"apc_list":{"value":2042,"currency":"GBP","value_usd":2693},"apc_paid":null,"fwci":13.792,"has_fulltext":true,"cited_by_count":305,"citation_normalized_percentile":{"value":0.99316213,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"13","issue":"1","first_page":"71","last_page":"82"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/riluzole","display_name":"riluzole","score":0.9139999747276306},{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.7940000295639038},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.9670000076293945},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.9259999990463257},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.843999981880188},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.8389999866485596},{"id":"https://openalex.org/keywords/glutamate-modulation","display_name":"glutamate modulation","score":0.8429999947547913},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.7350000143051147},{"id":"https://openalex.org/keywords/psychotomimetic-side-effects","display_name":"psychotomimetic side effects","score":0.8730000257492065},{"id":"https://openalex.org/keywords/continuation-therapy","display_name":"continuation treatment","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C2779319286","wikidata":"https://www.wikidata.org/wiki/Q415744","display_name":"Riluzole","level":4,"score":0.8734378218650818},{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.7920386791229248},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7189837694168091},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.6733925938606262},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.643517017364502},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5296521186828613},{"id":"https://openalex.org/C2777342061","wikidata":"https://www.wikidata.org/wiki/Q7836891","display_name":"Treatment-resistant depression","level":4,"score":0.5285010933876038},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.49933886528015137},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.47038212418556213},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4529688060283661},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.424604207277298},{"id":"https://openalex.org/C2781245242","wikidata":"https://www.wikidata.org/wiki/Q407781","display_name":"Dextromethorphan","level":2,"score":0.41345474123954773},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.34344279766082764},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27559593319892883},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.2222651243209839},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1691330075263977},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006213","descriptor_name":"Hallucinogens","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019782","descriptor_name":"Riluzole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1017/s1461145709000169","doi":"https://doi.org/10.1017/s1461145709000169","is_oa":false,"landing_page_url":"https://doi.org/10.1017/s1461145709000169","pdf_url":null,"source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmid:19288975","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19288975","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of neuropsychopharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire/80e9d99c-2ca6-4847-b8a6-eeb0de1b32fb","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/80e9d99c-2ca6-4847-b8a6-eeb0de1b32fb","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mathew, S J, Murrough, J W, Aan het Rot, M, Collins, K A, Reich, D L & Charney, D S 2010, 'Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression : a pilot randomized, placebo-controlled continuation trial', International Journal of Neuropsychopharmacology, vol. 13, no. 1, pp. 71 - 82. https://doi.org/10.1017/S1461145709000169","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:europepmc.org:2871198","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3883127","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3883127","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3883127/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Int J Neuropsychopharmacol","raw_type":"Text"},{"id":"pmh:rug:oai:pure.rug.nl:publications/80e9d99c-2ca6-4847-b8a6-eeb0de1b32fb","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/80e9d99c-2ca6-4847-b8a6-eeb0de1b32fb","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Neuropsychopharmacology, 13(1), 71 - 82. Cambridge University Press","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pure.rug.nl:openaire/80e9d99c-2ca6-4847-b8a6-eeb0de1b32fb","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/80e9d99c-2ca6-4847-b8a6-eeb0de1b32fb","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mathew, S J, Murrough, J W, Aan het Rot, M, Collins, K A, Reich, D L & Charney, D S 2010, 'Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression : a pilot randomized, placebo-controlled continuation trial', International Journal of Neuropsychopharmacology, vol. 13, no. 1, pp. 71 - 82. https://doi.org/10.1017/S1461145709000169","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G2031539936","display_name":"PROTON MRS STUDIES IN GENERALIZED ANXIETY DISORDER","funder_award_id":"K23MH069656","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G4627133822","display_name":null,"funder_award_id":"MO1RR00071","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G4762460169","display_name":"General Clinical Research Center","funder_award_id":"M01RR000071","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G9000225220","display_name":null,"funder_award_id":"MO1-RR-00071","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320311440","display_name":"National Alliance for Research on Schizophrenia and Depression","ror":"https://ror.org/03a63f080"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W183123008","https://openalex.org/W1914381346","https://openalex.org/W1967308562","https://openalex.org/W1970133878","https://openalex.org/W1984754469","https://openalex.org/W1985285470","https://openalex.org/W1993254538","https://openalex.org/W1996311338","https://openalex.org/W2000031234","https://openalex.org/W2002398205","https://openalex.org/W2013993405","https://openalex.org/W2014884007","https://openalex.org/W2016510258","https://openalex.org/W2020844317","https://openalex.org/W2021069714","https://openalex.org/W2023081218","https://openalex.org/W2024636695","https://openalex.org/W2026412461","https://openalex.org/W2028640606","https://openalex.org/W2031002884","https://openalex.org/W2031231313","https://openalex.org/W2032739515","https://openalex.org/W2036261911","https://openalex.org/W2039961483","https://openalex.org/W2039979496","https://openalex.org/W2047761238","https://openalex.org/W2052480734","https://openalex.org/W2061731402","https://openalex.org/W2067230536","https://openalex.org/W2071199266","https://openalex.org/W2071696563","https://openalex.org/W2074907255","https://openalex.org/W2077609442","https://openalex.org/W2080135883","https://openalex.org/W2081553996","https://openalex.org/W2086593869","https://openalex.org/W2088289750","https://openalex.org/W2093627402","https://openalex.org/W2093728671","https://openalex.org/W2097693778","https://openalex.org/W2097857685","https://openalex.org/W2105931591","https://openalex.org/W2109334244","https://openalex.org/W2119857283","https://openalex.org/W2123274136","https://openalex.org/W2127124395","https://openalex.org/W2127872798","https://openalex.org/W2130417276","https://openalex.org/W2131823335","https://openalex.org/W2132324173","https://openalex.org/W2133308299","https://openalex.org/W2134075154","https://openalex.org/W2137992068","https://openalex.org/W2144706922","https://openalex.org/W2153831898","https://openalex.org/W2167659819","https://openalex.org/W2410979608","https://openalex.org/W2415347870","https://openalex.org/W2465577389","https://openalex.org/W2777987555","https://openalex.org/W3090293687","https://openalex.org/W3174363935","https://openalex.org/W4229619638"],"related_works":["https://openalex.org/W2006861654","https://openalex.org/W2091235949","https://openalex.org/W2123488676","https://openalex.org/W2971894339","https://openalex.org/W2921871712","https://openalex.org/W4403830261","https://openalex.org/W2895197076","https://openalex.org/W2059761623","https://openalex.org/W2057804290","https://openalex.org/W4399963461"],"abstract_inverted_index":{"The":[0,156,197],"N-methyl-D-aspartate":[1],"(NMDA)":[2],"glutamate":[3],"receptor":[4],"antagonist":[5],"ketamine":[6,71,121,138,214],"may":[7,220],"have":[8,221],"rapid,":[9],"albeit":[10],"transient,":[11],"antidepressant":[12,63,127,225],"properties.":[13,226],"This":[14,204],"study":[15,206],"in":[16,44,143,169,217,232],"patients":[17,67,82,92,130,189],"with":[18,53,120,186],"treatment-resistant":[19],"major":[20],"depression":[21],"(TRD)":[22],"aimed":[23],"to":[24,80,85,113,141],"(1)":[25],"replicate":[26],"the":[27,37,40,102,115,233],"acute":[28],"efficacy":[29,38],"of":[30,39,152,188,212,240],"single-dose":[31],"intravenous":[32],"(i.v.)":[33],"ketamine;":[34],"(2)":[35],"test":[36],"glutamate-modulating":[41],"agent":[42],"riluzole":[43,153,172,192],"preventing":[45],"post-ketamine":[46,244],"relapse;":[47],"and":[48,60,122,139,173,219,223],"(3)":[49],"examine":[50],"whether":[51],"pretreatment":[52],"lamotrigine":[54,86],"would":[55],"attenuate":[56,114],"ketamine's":[57],"psychotomimetic":[58],"effects":[59],"enhance":[61,125],"its":[62,126],"activity.":[64],"Twenty-six":[65],"medication-free":[66],"received":[68],"open-label":[69],"i.v.":[70,213],"(0.5":[72],"mg/kg":[73],"over":[74],"40":[75],"min).":[76],"Two":[77],"hours":[78],"prior":[79],"infusion,":[81],"were":[83],"randomized":[84],"(300":[87],"mg)":[88],"or":[89],"placebo.":[90,196],"Seventeen":[91],"(65%)":[93],"met":[94,132],"response":[95,133],"criterion":[96,134],"(50%":[97],"reduction":[98],"from":[99],"baseline":[100],"on":[101,191,195],"Montgomery-Asberg":[103],"Depression":[104],"Rating":[105],"Scale)":[106],"24":[107],"h":[108,136],"following":[109,137,236],"ketamine.":[110,237],"Lamotrigine":[111],"failed":[112],"mild,":[116],"transient":[117],"side-effects":[118],"associated":[119],"did":[123,228],"not":[124,229],"effects.":[128],"Fourteen":[129],"(54%)":[131],"72":[135],"proceeded":[140],"participate":[142],"a":[144,209],"32-d,":[145],"randomized,":[146],"double-blind,":[147],"placebo-controlled,":[148],"flexible-dose":[149],"continuation":[150],"trial":[151,198],"(100-200":[154],"mg/d).":[155],"main":[157],"outcome":[158],"measure":[159],"was":[160,199],"time-to-relapse.":[161],"An":[162],"interim":[163],"analysis":[164],"found":[165],"no":[166],"significant":[167],"differences":[168],"time-to-relapse":[170],"between":[171],"placebo":[174],"groups":[175],"[log-rank":[176],"chi(2)":[177],"=":[178,181,184],"0.17,":[179],"d.f.":[180],"1,":[182],"p":[183],"0.68],":[185],"80%":[187],"relapsing":[190],"vs.":[193],"50%":[194],"thus":[200],"stopped":[201],"for":[202],"futility.":[203],"pilot":[205],"showed":[207],"that":[208],"sub-anaesthetic":[210],"dose":[211],"is":[215,245],"well-tolerated":[216],"TRD,":[218],"rapid":[222],"sustained":[224],"Riluzole":[227],"prevent":[230],"relapse":[231,241],"first":[234],"month":[235],"Further":[238],"investigation":[239],"prevention":[242],"strategies":[243],"necessary.":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2107849028","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":22},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":31},{"year":2015,"cited_by_count":29},{"year":2014,"cited_by_count":32},{"year":2013,"cited_by_count":30},{"year":2012,"cited_by_count":20}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
